Final approval for diabetes and heart-failure drug opens access to a $10.5 billion US market opportunity, with shared exclusivity benefits.
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
The company’s broader OX2R portfolio includes clinical and preclinical assets with potential applications across neurological, neurodegenerative, and neuropsychiatric conditions
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
Alkem’s semaglutide comes in a pre-filled disposable injection pen containing four doses for a month, priced at Rs. 1,800
The once-weekly treatment targets Type 2 Diabetes Mellitus (T2DM) with demonstrated efficacy and safety
Targets diabetes & obesity crisis as India grapples with soaring metabolic disorders
Zydus has developed an innovative formulation of Semaglutide Injection in a prefilled cartridge administered using a reusable patient-friendly pen device
Subscribe To Our Newsletter & Stay Updated
